KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Non Operating Investment Income: 2015-2016

Historic Non Operating Investment Income for Teva Pharmaceutical Industries (TEVA) over the last 2 years, with Dec 2016 value amounting to $2.0 million.

  • Teva Pharmaceutical Industries' Non Operating Investment Income was N/A to $3.0 million in Q1 2017 from the same period last year, while for Mar 2017 it was $7.0 million, marking a year-over-year change of. This contributed to the annual value of $2.0 million for FY2016, which is 81.82% down from last year.
  • According to the latest figures from FY2016, Teva Pharmaceutical Industries' Non Operating Investment Income is $2.0 million, which was down 81.82% from $11.0 million recorded in FY2015.
  • Over the past 5 years, Teva Pharmaceutical Industries' Non Operating Investment Income peaked at $11.0 million during FY2015, and registered a low of $2.0 million during FY2016.
  • In the last 2 years, Teva Pharmaceutical Industries' Non Operating Investment Income had a median value of $6.5 million in 2015 and averaged $6.5 million.
  • Data for Teva Pharmaceutical Industries' Non Operating Investment Income shows a maximum YoY slumped of 81.82% (in 2016) over the last 5 years.
  • Teva Pharmaceutical Industries' Non Operating Investment Income (Yearly) stood at $11.0 million in 2015, then crashed by 81.82% to $2.0 million in 2016.